Search

Author/Creator Han, Sang Y.

1. Efficacy, safety and albuminuria‐reducing effect of gemigliptin in Korean type 2 diabetes patients with moderate to severe renal impairment: A 12‐week, double‐blind randomized study (the GUARD Study). Issue 4 (17th February 2017)

Authors:
Yoon, Sun A.; Han, Byoung G.; Kim, Sung G.; Han, Sang Y.; Jo, Young I.; Jeong, Kyung H.; Oh, Kook H.; Park, Hyeong C.; Park, Sun H.; Kang, Shin W.; Na, Ki R.; Kang, Sun W.; Kim, Nam H.; Jang, Young H.; Shin, Seong H.; Cha, Dae R.
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 19:Issue 4(2017)
Page Start:
590
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Safety and metabolic advantages of steroid withdrawal after 6 months posttransplant in de novo kidney transplantation: A 1‐year prospective cohort study. Issue 3 (15th December 2021)

Authors:
Bang, Jun B.; Oh, Chang‐Kwon; Kim, Yu S.; Kim, Sung H.; Yu, Hee C.; Kim, Chan‐Duck; Ju, Man Ki; So, Byung J.; Lee, Sang Ho; Han, Sang Y.; Jung, Cheol W.; Kim, Joong K.; Ahn, Hyung J.; Lee, Su H.; Jeon, Ja Y.
Journal:
Immunity, inflammation and disease
Issue:
Volume 10:Issue 3(2022)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗